CO.DON AGCO.DON AGCO.DON AG

CO.DON AG

No trades
See on Supercharts

CNW fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. Its customers include accident surgeons, orthopaedic surgeons, and neurosurgeons in clinics and specialised practices. The firms main product Spherox is a three-dimensional chondrocyte product used to treat articular cartilage defects in the knee with autologous cells by means of matrix-associated autologous chondrocyte transplantation. The company was founded in 1993 and is headquartered in Teltow, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CNW does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company